Teradyne Q3 Revenue Beats Guidance but Margin Question Remains

What happened

Teradyne's Q3 2026 earnings call revealed revenue above $1.3 billion, up 70% year-over-year, driven by continued AI demand across semiconductor test, product test, and robotics. This revenue level exceeded the high end of management's prior guidance of $1.20–$1.30 billion, reducing immediate concerns about a demand pause in AI-related tester installations. However, the news snippet does not provide details on operating margins, which fell to 32.9% in Q2 from 36.9% in Q1, and the master report identified margin recovery above 35% as a necessary condition for an upgrade. With the stock trading at 49.6x trailing earnings and 73.8x EV/EBITDA, the strong revenue beat may not be sufficient to overcome valuation and profitability concerns. Investors should await the full 10-Q filing to assess segment mix, margin trajectory, and robotics losses before changing the investment stance.

Implication

The Q3 revenue beat of above $1.3 billion (up 70% YoY) exceeds the high end of guidance and signals that AI-driven semiconductor test demand remains robust, reducing immediate revenue risk. However, Teradyne's Q2 operating margin fell to 32.9% from 36.9% in Q1, and the earnings call reference does not clarify whether margin pressure has abated, so the key trigger of operating margin above 35% remains unconfirmed. With the stock trading at 49.6x trailing earnings and 73.8x EV/EBITDA, even a strong revenue beat may not be enough to justify upside if margins do not recover. Investors should focus on the full income statement and segment details from the 10-Q, particularly Semiconductor Test mix and robotics losses, to assess whether earnings quality is improving. Until operating margin recovers and the margin of safety improves, holding a WAIT with disciplined buying below $315 or after confirmed margin expansion remains appropriate.

Thesis delta

The Q3 revenue beat of above $1.30B satisfies one of the two conditions necessary for an upgrade from WAIT, as it reduces the risk of a semiconductor test demand pause. However, the second condition—operating margin returning above 35%—has not yet been confirmed by the news snippet, and the master report's concern about margin erosion and rich valuation persists. Therefore, the thesis remains intact but unchanged: WAIT, with a potential upgrade if margin recovery is evidenced in the full Q3 filing and subsequent guidance.